Legal & General Group
DSGN icon

Legal & General Group’s Design Therapeutics DSGN Stock Holding History

Legal & General Group’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.1K Hold
2,077
– – ﹤0.01% 2929
2025
Q4 		$19.5K Hold
2,077
– – ﹤0.01% 3039
2025
Q3 		$15.7K Sell
2,077
-1,001
-33% -$5.01K ﹤0.01% 3146
2025
Q2 		$10.4K Buy
3,078
+513
+20% +$1.92K ﹤0.01% 3279
2025
Q1 		$9.91K Hold
2,565
– – ﹤0.01% 3173
2024
Q4 		$15.8K Hold
2,565
– – ﹤0.01% 3111
2024
Q3 		$13.8K Hold
2,565
– – ﹤0.01% 3187
2024
Q2 		$8.59K Hold
2,565
– – ﹤0.01% 3327
2024
Q1 		$10.3K Hold
2,565
– – ﹤0.01% 3193
2023
Q4 		$6.8K Hold
2,565
– – ﹤0.01% 3288
2023
Q3 		$6.05K Sell
2,565
-562
-18% -$2.62K ﹤0.01% 3349
2023
Q2 		$19.7K Hold
3,127
– – ﹤0.01% 3115
2023
Q1 		$18K Hold
3,127
– – ﹤0.01% 3092
2022
Q4 		$32.1K Hold
3,127
– – ﹤0.01% 3037
2022
Q3 		$52K Sell
3,127
-120
-4% -$2.39K ﹤0.01% 2964
2022
Q2 		$45K Buy
3,247
+711
+28% +$9.6K ﹤0.01% 3019
2022
Q1 		$41K Buy
2,536
+73
+3% +$1.12K ﹤0.01% 3033
2021
Q4 		$53K Buy
2,463
+1,187
+93% +$20.4K ﹤0.01% 3019
2021
Q3 		$19K Hold
1,276
– – ﹤0.01% 3293
2021
Q2 		$26K Sell
1,276
-59,224
-98% -$1.49M ﹤0.01% 3190
2021
Q1 		$1.83M Buy
+60,500
New +$2.04M ﹤0.01% 2014

Other funds holding DSGN

SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Legal & General Group's DSGN Position: Q1 2026 in Review

Legal & General Group held its Design Therapeutics (DSGN) position steady in Q1 2026 at 2,077 shares worth $22.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2929.

Legal & General Group first reported a position in DSGN in Q1 2021 and has held it in 21 quarters since. The position peaked at $1.83M in Q1 2021. 125 funds tracked by Wall St. Rank hold DSGN as of Q1 2026.

  • Legal & General Group held 2,077 shares of Design Therapeutics worth $22.1K as of Q1 2026.
  • Legal & General Group left its Design Therapeutics share count unchanged in Q1 2026.
  • Design Therapeutics made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2929 holding.
  • Legal & General Group first reported a position in Design Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Legal & General Group's Design Therapeutics position peaked at $1.83M in Q1 2021.
  • 125 funds tracked by Wall St. Rank held Design Therapeutics as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.